Search

everythinglearnresearchcommunity

for

Search:↓

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Targeting TRP channels may help reduce excessive scarring.

PRP injections help relieve hip pain in most cases.

Phenylephrine may help prevent hair loss from pulling on the hair roots.

Naltrexone did not significantly reduce hair pulling but improved cognitive flexibility.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.